Short report: molecular markers associated with Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in the Democratic Republic of Congo. [PDF]
Sulfadoxine-pyrimethamine (SP) is the first line antimalarial treatment in the Democratic Republic of Congo. Using polymerase chain reaction, we assessed the prevalence of mutations in the dihydrofolate reductase (dhfr) (codons 108, 51, 59) and ...
Bonnet, M +5 more
core +2 more sources
In vivo antimalarial drug efficacy studies of uncomplicated Plasmodium falciparum malaria at an isolated site in the Amazon basin of Peru bordering Brazil and Colombia showed >50% RII/RIII resistance to sulfadoxine-pyrimethamine but no evidence of ...
Alan J. Magill +4 more
doaj
<i>Plasmodium falciparum</i> field isolates drug susceptibility in Mali. [PDF]
Maiga FO +11 more
europepmc +1 more source
Molecular markers of antimalarial drug resistance in pfk13, pfmdr1, pfdhfr, and pfdhps genes of Plasmodium falciparum in a rural municipality in Cubal, Benguela Province, Angola (2022-2023). [PDF]
Mediavilla A +15 more
europepmc +1 more source
Mechanistic perspectives on antimalarial agents: from FDA-approved drugs to next-generation candidates. [PDF]
Monika, Sharma B, Awasthi SK.
europepmc +1 more source
The Global Landscape of <i>Plasmodium falciparum</i> Drug Resistance Markers, 2005-2025: A Systematic Review and Meta-Analysis. [PDF]
Habarugira F +8 more
europepmc +1 more source
Targeted Genomic Surveillance Unveils Genetic Variations Linked to Regional Malaria Drug Resistance Dynamics in India. [PDF]
Khilari A +8 more
europepmc +1 more source
Extreme weather events and malaria prevention in pregnancy: a mediation analysis of antenatal care and sulfadoxine-pyrimethamine use in two malaria-endemic counties of Kenya. [PDF]
Matanda DJ +6 more
europepmc +1 more source
Whole genome sequencing to inform the epidemiology of Plasmodium falciparum malaria in the elimination setting of Malaysia. [PDF]
Tan MKI +7 more
europepmc +1 more source

